中医药在骨质疏松中的作用研究进展
Research Progress in the Role of Traditional Chinese Medicine in Osteoporosis
DOI: 10.12677/TCM.2023.123103, PDF,   
作者: 严 莹：上海市普陀区真如镇街道社区卫生服务中心，上海
关键词: 骨质疏松；中医；中药；研究进展；Osteoporosis； Traditional Chinese Medicine； Chinese Medicine； Research Progress
摘要: 骨质疏松症是一种以骨量减少和骨细胞微结构退化为特征的系统性骨残疾，导致骨骼虚弱和骨折易损性增加。它是一种多基因、生理性的骨骼畸形，经常导致骨质疏松性骨折，并在创伤中增加骨折的风险。中医是一门传统疗法的学科，在“上医治未病”等理论指导下，包括草药疗法、推拿疗法、针灸疗法等也在治疗骨质疏松症取得了巨大成功，且副作用小，由此越来越受欢迎。因此，本文主要就中医药在骨质疏松症中的作用进行论述，以期为其临床研究提供一定的理论基础。
Abstract: Osteoporosis is a systemic bone disability characterized by reduced bone mass and degradation of bone cell microstructure, leading to bone weakness and increased fracture vulnerability. It is a polygenic, physiological skeletal deformity that often leads to osteoporotic fractures and increases the risk of fractures in trauma. Traditional Chinese Medicine is a subject of traditional therapy. Under the guidance of the theory of “treating terminal diseases”, herbal therapy, massage therapy, acupuncture therapy also have achieved great success in the treatment of osteoporosis, and the side effects are very small. Therefore, this article mainly discusses the role of traditional Chinese medicine in osteoporosis in order to provide a theoretical basis for its clinical research.
文章引用：严莹. 中医药在骨质疏松中的作用研究进展[J]. 中医学, 2023, 12(3): 675-680. https://doi.org/10.12677/TCM.2023.123103

参考文献

[1] Miller, P.D. (2016) Management of Severe Osteoporosis. Expert Opinion on Pharmacotherapy, 17, 473-488. [Google Scholar] [CrossRef] [PubMed]
[2] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐杂志, 2017, 10(5): 413.
[3] Biver, E. and Ferrari, S. (2020) Osteoporosis. Revue Medicale Suisse, 16, 78-80. [Google Scholar] [CrossRef] 
[4] Reid, I.R. (2020) A Broader Strategy for Osteoporosis Interventions. Nature Reviews Endocrinology, 16, 333-339. [Google Scholar] [CrossRef] [PubMed]
[5] Wang, T., Liu, Q., Tjhioe, W., et al. (2017) Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis. Current Drug Targets, 18, 1051-1068. [Google Scholar] [CrossRef] [PubMed]
[6] Xiao, Y.P., Zeng, J., Jiao, L.N., et al. (2018) Review for Treatment Effect and Signaling Pathway Regulation of Kidney-Tonifying Traditional Chinese Medicine on Osteoporosis. China Journal of Chinese Materia Medica, 43, 21-30.
[7] Suvarna, V., Sarkar, M., Chaubey, P., et al. (2018) Bone Health and Natural Products—An Insight. Frontiers in Pharmacology, 9, 981. [Google Scholar] [CrossRef] [PubMed]
[8] He, J.B., Chen, M.H. and Lin, D.K. (2017) New Insights into the Tonifying Kidney-Yin Herbs and Formulas for the Treatment of Osteoporosis. Archives of Osteoporosis, 12, 14. [Google Scholar] [CrossRef] [PubMed]
[9] 邓昶, 周明旺, 付志斌, 等. 骨质疏松症的中医病因病机及其治疗进展[J]. 中国骨质疏松杂志, 2017, 23(8): 1105-1111.
[10] Li, Y., Tong, J., Zhou, Y.J., et al. (2015) Research Progress on Anti-Osteoporotic Active Ingredients and Pharmacological Action Mechanism of Traditional Chinese Kidney-Tonifying and Bone-Strengthening Drugs. China Journal of Chinese Materia Medica, 40, 1038-1043.
[11] 梁伟乔, 钟诚, 李宇明. 骨质疏松症的中医病因病机认识与治疗进展[J]. 中国骨质疏松杂志, 2020, 26(1): 135-139.
[12] 王晶, 许金海. 骨质疏松症与中医体质类型关系的Meta分析[J]. 中医正骨, 2022, 34(6): 29-33+52.
[13] Zhang, X., Robles, H., Magee, K.L., et al. (2021) A Bone-Specific Adipogenesis Pathway in Fat-Free Mice Defines Key Origins and Adaptations of Bone Marrow Adipocytes with Age and Disease. eLife, 10, e66275. [Google Scholar] [CrossRef] 
[14] 权祯, 秦大平, 张晓刚, 等. 基于中医“治未病”理念探讨其对骨质疏松症可控性危险因素的防治策略[J]. 中国骨质疏松杂志, 2021, 27(5): 747-752+758.
[15] Mukwaya, E., Xu, F., Wong, M.S., et al. (2014) Chinese Herbal Medicine for Bone Health. Pharmaceutical Biology, 52, 1223-1228. [Google Scholar] [CrossRef] [PubMed]
[16] Rufus, P., Mohamed, N. and Shuid, A.N. (2013) Beneficial Effects of Traditional Chinese Medicine on the Treatment of Osteoporosis on Ovariectomised Rat Models. Current drug Targets, 14, 1689-1693. [Google Scholar] [CrossRef] [PubMed]
[17] 杨璐尧, 刘翠莲. 中药淫羊藿苷抗骨质疏松的研究进展[J]. 产业与科技论坛, 2021, 20(1): 63.
[18] Liu, R., Kang, X., Xu, L., et al. (2015) Effect of the Combined Extracts of Herba Epimedii and Fructus Ligustri Lucidi on Sex Hormone Functional Levels in Osteoporosis Rats. Evidence-Based Complementary and Alternative Medicine: eCAM, 2015, Article ID: 184802. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, L., Li, Y., Guo, Y., et al. (2016) Herba Epimedii: An Ancient Chinese Herbal Medicine in the Prevention and Treatment of Osteoporosis. Current Pharmaceutical Design, 22, 328-349. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, Z.Q., Li, J.L., Sun, Y.L., et al. (2013) Chinese Herbal Medicine for Osteoporosis: A Systematic Review of Randomized Controlled Trails. Evidence-Based Complementary and Alternative Medicine: eCAM, 2013, Article ID: 356260. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, M., Li, Y. and Yang, S.T. (2017) Effects of Naringin on the Proliferation and Osteogenic Differentiation of Human Amniotic Fluid-Derived Stem Cells. Journal of Tissue Engineering and Regenerative Medicine, 11, 276-284. [Google Scholar] [CrossRef] [PubMed]
[22] 高文鑫, 陈云刚, 姚康, 等. 骨碎补治疗骨质疏松症的实验研究进展[J]. 中国骨质疏松杂志, 2022, 28(11): 1683-1689.
[23] 邓强, 乔小万, 李中锋, 等. 骨碎补活性成分治疗骨骼系统疾病研究进展[J]. 辽宁中医药大学学报, 2022, 24(7): 1-5.
[24] Ramchandani, D., Ganeshpurkar, A., Bansal, D., et al. (2014) Protective Effect of Curculigo Orchioides Extract on Cyclophosphamide-Induced Neurotoxicity in Murine Model. Toxicology International, 21, 232-235. [Google Scholar] [CrossRef] [PubMed]
[25] Vickers, N.J. (2017) Animal Communication: When I’m Calling You, Will You Answer Too? Current Biology: CB, 27, R713-R715. [Google Scholar] [CrossRef] [PubMed]
[26] Hejazi, I.I., Khanam, R., Mehdi, S.H., et al. (2018) Antioxidative and Anti-Proliferative Potential of Curculigo orchioides Gaertn in Oxidative Stress Induced Cytotoxicity: In Vitro, ex Vivo and in Silico Studies. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 115, 244-259. [Google Scholar] [CrossRef] [PubMed]
[27] 郭鱼波, 马如风, 王丽丽, 等. 女贞子治疗骨质疏松作用及其机制的研究进展[J]. 中草药, 2016, 47(5): 851-856.
[28] 陈儒骜, 郭雨霏, 董慧静, 等. 女贞子防治骨质疏松作用的中医理论探讨[J]. 中国中医基础医学杂志, 2022, 28(2): 201-204+209.
[29] 韦秋, 侯佳华, 覃小燕, 等. 女贞子多糖抗去势小鼠骨质疏松作用研究[J]. 天津中医药, 2022, 39(1): 104-109.
[30] Zhang, R., Liu, Z.G., Li, C., et al. (2009) Du-Zhong (Eucommia ulmoides Oliv.) Cortex Extract Prevent OVX-Induced Osteoporosis in Rats. Bone, 45, 553-559. [Google Scholar] [CrossRef] [PubMed]
[31] He, X., Wang, J., Li, M., et al. (2014) Eucommia ulmoides Oliv.: Ethnopharmacology, Phytochemistry and Pharmacology of an Important Traditional Chinese Medicine. Journal of Ethnopharmacology, 151, 78-92. [Google Scholar] [CrossRef] [PubMed]
[32] Li, Y., Li, L., Li, X., et al. (2022) A Mechanistic Review of Chinese Medicine Polyphenols on Bone Formation and Resorption. Frontiers in Pharmacology, 13, Article ID: 1017538. [Google Scholar] [CrossRef] [PubMed]
[33] 郑洁, 郭海英, 潘思京, 等. 针灸治疗原发性骨质疏松症临床研究进展[J]. 河北中医, 2014, 36(8): 1254-1257.
[34] 岑卓灏, 陈洁娜, 黄嘉华, 等. 针灸联合多种方法治疗骨质疏松的网状Meta分析[J]. 中国组织工程研究, 2020, 24(2): 320-328.
[35] 康轶鑫, 王道全, 刘忠厚. 推拿治疗骨质疏松症的研究进展[J]. 中国骨质疏松杂志, 2010, 16(4): 300-307.